 - These drugs should not be given during the patients participation in the study, and must be stopped 6 weeks before randomisation : lipid lowering drug other than study medication, Cyclosporine A, medical treatment against obesity i.e., Orlistat, Sibutramine, oral anticoagulants. Special attention will be paid to the medications that could interfere with the lipid profile i.e. oral corticosteroids, retinoids, thyroid hormones, thiazide derivative, diuretics, beta-blockers, and hormone replacement therapies. It is recommended not to modify these medications within 6 weeks prior to study start and during the course of the trial unless this is medically required. All concomitant medications will be recorded. 